Evidence map›Paper›PMID 30213141›Full record

ArticleJournal of clinical medicine2018

Development of a Prediction Model for Colorectal Cancer among Patients with Type 2 Diabetes Mellitus Using a Deep Neural Network.

Meng-Hsuen Hsieh, Li-Min Sun, Cheng-Li Lin, Meng-Ju Hsieh, Kyle Sun, Chung-Y Hsu, An-Kuo Chou, Chia-Hung Kao

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Nomogram for Predicting Risk of Digestive Carcinoma Among Patients with Type 2 Diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Meng-Hsuen HsiehDepartment of Electrical Engineering and Computer Sciences, University of California, Berkeley, CA 94720, USA. emersonhsieh@berkeley.edu.
Li-Min SunDepartment of Radiation Oncology, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung 81342, Taiwan. limin.sun@yahoo.com.
Cheng-Li LinManagement Office for Health Data, China Medical University Hospital, Taichung 40447, Taiwan. orangechengli@gmail.com.
Meng-Ju HsiehDepartment of Medicine, Poznan University of Medical Sciences, 61-701 Poznań, Poland. 76519@student.ump.edu.pl.ORCID 0000-0001-5856-3840
Kyle SunProgram of Computer Science, Arizona State University, Tempe, AZ 85287, USA. yaomon18@yahoo.com.
Chung-Y HsuGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan. hsucy63141@gmail.com.
An-Kuo ChouCollege of Medicine, China Medical University, Taichung 40402, Taiwan. edmundchou@gmail.com.
Chia-Hung KaoGraduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan. d10040@mail.cmuh.org.tw.ORCID 0000-0002-6368-3676
China Medical University · TWPoznan University of Medical Sciences · PLArizona State University · USAsia University · TWKaohsiung Armed Forces General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesObservational studies suggested that patients with type 2 diabetes mellitus (T2DM) presented a higher risk of developing colorectal cancer (CRC). The current study aims to create a deep neural network (DNN) to predict the onset of CRC for patients with T2DM.

methodsWe employed the national health insurance database of Taiwan to create predictive models for detecting an increased risk of subsequent CRC development in T2DM patients in Taiwan. We identified a total of 1,349,640 patients between 2000 and 2012 with newly diagnosed T2DM. All the available possible risk factors for CRC were also included in the analyses. The data were split into training and test sets with 97.5% of the patients in the training set and 2.5% of the patients in the test set. The deep neural network (DNN) model was optimized using Adam with Nesterov's accelerated gradient descent. The recall, precision, F₁ values, and the area under the receiver operating characteristic (ROC) curve were used to evaluate predictor performance.

resultsThe F₁, precision, and recall values of the DNN model across all data were 0.931, 0.982, and 0.889, respectively. The area under the ROC curve of the DNN model across all data was 0.738, compared to the ideal value of 1. The metrics indicate that the DNN model appropriately predicted CRC. In contrast, a single variable predictor using adapted the Diabetes Complication Severity Index showed poorer performance compared to the DNN model.

conclusionsOur results indicated that the DNN model is an appropriate tool to predict CRC risk in patients with T2DM in Taiwan.

Indexed as

colorectal cancerdeep neural networkreceiver operating characteristicthe national health insurance databasetype 2 diabetes mellitus

Identifiers

PMID30213141
PMCPMC6162847
OpenAlexW2889815395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.